River Road Loads with 917k Shares in AptarGroup Bet
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
Value Of Robo Advisor Fees Vs Returns
Compare how robo advisor fees stack up against potential returns to help you decide if automation fits your investing plan. This intro explains the core cost-benefit idea in plain terms.
22,067 articles
Down 20%, Oracle No-Brainer AI Buy: A Practical Guide
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Rocket Sues UWM for $100M, Claiming Covenant Breach
Rocket Mortgage has filed suit against United Wholesale Mortgage, seeking about $100 million in damages over alleged ...
Motorola's $1.5 Billion D-Fend: A Bold Move in Public Safety Tech
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Apple Raising Prices Higher: Is the Stock in Trouble?
Rising memory costs are pushing Apple to raise prices higher. This article examines how that could affect margins, de...
Slack Cofounder Says Workers Are Slipping Into Fake Work
A rising productivity framework argues that some workplace tasks look busy but deliver little real value. This could ...
Bidding Emerges as Two Harbors Rival Pressures UWM Markets
A fresh cash bid for Two Harbors Investment Corp. sparks a renewed bidding war, putting pressure on UWM to top terms ...
Celcuity (CELC) 2026 Earnings: What Investors Need
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
Harriet Sperling Turned Princess: Wedding Dress Lessons
A private wedding can teach big budgeting and style lessons. Harriet Sperling turned Princess illustrates how choosin...
Apple Actually Benefit From Memory Shortage: A Catalyst for Growth
The global memory shortage is shaking up pricing and supply chains. This article explains how Apple can actually bene...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Taysha (TSHA) 2025 Earnings Outlook and Q4 Review
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status